| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,390 | $100 | $140.4K |
| J0897 | Injection, denosumab, 1 mg | 4,920 | $20 | $93.5K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,500 | $20 | $76.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 680 | $110 | $73.1K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 9,500 | $10 | $57K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 560 | $70 | $37.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 220 | $150 | $32.3K |
| J1952 | Leuprolide injectable, camcevi, 1 mg | 460 | $60 | $27.3K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 70 | $330 | $24.7K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 250 | $100 | $24.3K |